Discover insights into Anavex's ATTENTION-AD OLE trial results for early Alzheimer's, presented at AD/PD 2025. Click here to read my latest analysis.

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium.

Researchers studying Alzheimer’s disease are using artificial intelligence ... But it took leveraging a knowledge graph, a database technology popularized by Google over a decade ago for its ...

A simpler method of analyzing blood samples for Alzheimer's disease has been tested in a large multi-center study.

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of ...